The partnership will connect Evogene’s AI-based ChemPass AI with the BCDD’s laboratory infrastructure.

This Collection supports and amplifies research related to SDG 3: Good Health & Wellbeing and SDG 17: Partnerships for the Goals. The rapid evolution of artificial intelligence (AI) is reshaping the ...

The in silico protein design market offers key opportunities in AI-driven drug discovery, personalized medicine, and automation in biological research. With cloud-based simulation growth, partnerships ...

Eli Lilly chief information and digital officer Diogo Rau was recently involved in some experiments in the office, but not the typical drug research work that you might expect to be among the lab ...

Harnessing bacterial enzymes to develop drug variants, a strategy known as combinatorial biosynthesis, has long been a goal ...

RNA interference is a natural mechanism for living cells to control whether specific genes are being used or not.

Experts have been raising concerns about “AI washing.” One of these experts, futurist Bernard Marr, has said that AI washing “involves exaggerating the capabilities of a product or service that is ...

Google DeepMind announced the launch of AlphaProteo, an AI system to help biological and health researchers design novel, high-strength proteins that bind to target molecules with accuracy and ...

When machine learning is used to suggest new potential scientific insights or directions, algorithms sometimes offer solutions that are not physically sound. Take, for example, AlphaFold, the AI ...

Some proteins in the human body are easy to block with a drug; they have an obvious spot in their structure where a drug can fit, like a key in a lock. But other proteins are more difficult to target, ...